Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomised, Controlled Trial of MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder

NCT05709353 is registered in ClinicalTrials.gov with University of Sydney as lead sponsor.

NCT NCT05709353
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05709353 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomised, Controlled Trial of MDMA-assisted Prolonged Exposure Therapy for Comorbid Alcohol Use Disorder and Post-traumatic Stress Disorder
Lead sponsor
University of Sydney
Phase
Phase 2
Overall status
Unknown status
Start date
September 19, 2023
Completion date
May 31, 2026
Enrollment
120 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol dependence, alcohol use disorder, comorbidities and coexisting conditions, post-traumatic stress disorder, ptsd